Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Extemporaneous Ophthalmic Preparations [[electronic resource] /] / by Eman Ali Saeed Alghamdi, Abdulmalik Yahya Al Qahtani, Mazen M. Sinjab, Khalid Mohammed Alyahya
| Extemporaneous Ophthalmic Preparations [[electronic resource] /] / by Eman Ali Saeed Alghamdi, Abdulmalik Yahya Al Qahtani, Mazen M. Sinjab, Khalid Mohammed Alyahya |
| Autore | Alghamdi Eman Ali Saeed |
| Edizione | [1st ed. 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (116 pages) |
| Disciplina | 617.7061 |
| Soggetto topico |
Ophthalmology
Pharmacy Pharmacology Drug Safety and Pharmacovigilance Pharmacology/Toxicology |
| ISBN | 3-030-27492-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section 1: Introduction to Extemporaneous Ophthalmic Preparations -- Chapter 1 Ocular Pharmacokinetics -- Chapter 2 Factors Affecting Bioavailability and Efficacy of Topical Eye Preparations -- Chapter 3 Ideal Characteristics of Ophthalmic Drug Delivery System -- Chapter 4 Inert Substances Used in the Proration of Ophthalmic Products -- Chapter 5 Preservatives Used in Ophthalmic Preparations -- Section 2: Extemporaneous Topical Ophthalmic Formulations -- Chapter 6 Topical Ophthalmic Drug Forms -- Chapter 7 Extemporaneous Compounding of Ophthalmic Products -- Chapter 8 American Society of Hospital Pharmacists (ASHP) Guidelines on Pharmacy-Prepared Ophthalmic Products -- Chapter 9 Formulations of Extemporaneous Topical Ophthalmic Preparations -- Chapter 10 Extemporaneous Ophthalmic Preparations in Ocular Oncology -- Section 3: Extemporaneous Intraocular Injections. Chapter 11 Extemporaneous Intravitreal Injections -- Chapter 12 Extemporaneous Intracameral Injections -- Chapter 13 Formulations of Extemporaneous Intraocular Injections -- Section 4: Extemporaneous Sub Conjunctival Injections -- Chapter 14 Equipment -- Chapter 15 Steps for subconjunctival injections -- Chapter 16 Formulations of Extemporaneous Intraocular Injections. |
| Record Nr. | UNINA-9910373946603321 |
Alghamdi Eman Ali Saeed
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Group Sequential and Confirmatory Adaptive Designs in Clinical Trials [[electronic resource] /] / by Gernot Wassmer, Werner Brannath
| Group Sequential and Confirmatory Adaptive Designs in Clinical Trials [[electronic resource] /] / by Gernot Wassmer, Werner Brannath |
| Autore | Wassmer Gernot |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (XVI, 301 p. 44 illus.) |
| Disciplina | 615.50724 |
| Collana | Springer Series in Pharmaceutical Statistics |
| Soggetto topico |
Statistics
Biostatistics Pharmacy Pharmaceutical technology Statistics for Life Sciences, Medicine, Health Sciences Drug Safety and Pharmacovigilance Pharmaceutical Sciences/Technology |
| ISBN | 3-319-32562-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I Group Sequential Designs -- Repeated Significance Tests: Procedures with Equally Sized Stages -- Procedures with Unequally Sized Stages -- Confidence Intervals, p -Values, and Point Estimation -- Applications -- Part II Adaptive Confirmatory Designs with a Single Hypothesis: Adaptive Group Sequential Tests -- Decision Tools for Adaptive Designs -- Estimation and p-Values for Two-stage Adaptive Designs -- Adaptive Designs with Survival Data -- Part III Adaptive Designs with Multiple Hypotheses: Multiple Testing in Adaptive Designs -- Applications and Case Studies -- Appendix - Software for Adaptive Designs -- Index. |
| Record Nr. | UNINA-9910254066603321 |
|
Wassmer Gernot
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Herb-Drug Combinations [[electronic resource] ] : A New Complementary Therapeutic Strategy / / by Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble
| Herb-Drug Combinations [[electronic resource] ] : A New Complementary Therapeutic Strategy / / by Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble |
| Autore | Hemaiswarya Shanmugam |
| Edizione | [1st ed. 2022.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 |
| Descrizione fisica | 1 online resource (285 pages) |
| Disciplina | 016.61378 |
| Soggetto topico |
Pharmacology
Pharmacy Alternative medicine Pharmacovigilance Medicinal chemistry Complementary and Alternative Medicine Drug Safety and Pharmacovigilance Medicinal Chemistry Plantes medicinals Medicina alternativa Farmacologia |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 981-19-5125-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction -- Chapter 2. Measuring Herb-drug interaction and Synergy -- Chapter 3. Herb-Herb and Food-drug interactions -- Chapter 4. Pharmacokinetic interactions in synergistic herb-drug combinations -- Chapter 5. Antagonistic Herb-drug interactions -- Chapter 6. Synergistic Herb-drug interactions against bacteria -- Chapter 7. Synergistic herb-drug interactions against tuberculosis -- Chapter 8. Synergistic herb-drug interactions against viral diseases -- Chapter 9. Synergistic herb interactions with cardiovascular drugs -- Chapter 10. Synergistic herb interactions with anticancer drugs -- Chapter 11. Synergistic herb interactions with antidiabetic drugs -- Chapter 12. Synergistic herb-drug interactions against obesity -- Chapter 13. Synergistic Herb-Drug Interactions in Neurological Disorders -- Chapter 14. Synergistic Herb-drug interactions with antifungal and antiparasitic agents -- Chapter 15. Computational methods to study herb-drug interactions -- Chapter 16. Regulations and guidelines involving synergistic plant-drug interactions -- Chapter 17. Clinical trials on synergistic herb-drug interactions -- Chapter 18. QFuture prospects on synergistic herb-drug interactions -- Chapter 19. Conclusion. |
| Record Nr. | UNINA-9910616380603321 |
|
Hemaiswarya Shanmugam
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Maternal Drug Use and Infant Congenital Malformations [[electronic resource] /] / by Bengt Källén
| Maternal Drug Use and Infant Congenital Malformations [[electronic resource] /] / by Bengt Källén |
| Autore | Källén Bengt |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XVIII, 425 p. 16 illus. in color.) |
| Disciplina | 618.2 |
| Soggetto topico |
Obstetrics
Pharmacy Epidemiology Maternal and child health services Obstetrics/Perinatology/Midwifery Drug Safety and Pharmacovigilance Maternal and Child Health |
| ISBN |
9783030178970
9783030178987 (e-book) |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Background -- Maternal use of antacids or drugs for GERD and infant congenital malformations -- Maternal use of drugs for intestinal problems, except intestinal inflammations, and infant congenital malformations -- Maternal use of drugs for inflammatory intestinal disease and infant congenital malformations -- Maternal use of anti-obesity drugs and infant congenital malformations -- Maternal use of insulin or oral hypoglycemic drugs and infant congenital malformations.-Maternal use of vitamins and infant congenital malformations.-Maternal use of anticoagulants and hemostatic drugs and infant congenital malformations.-Maternal use of drugs for cardiovascular diseases and infant congenital malformations.-Maternal use of dermatological drugs and infant congenital malformations -- Maternal use of prolactin inhibitors or sex hormones and infant congenital malformations -- Maternal use of drugs for thyroid disease and infant congenital malformations -- Maternal systemic use of corticosteroids and infant congenital malformations -- Maternal use of hypophyseal or hypothalamic hormones and infant congenital malformations -- Maternal use of antibacterial or antifungal drugs and infant congenital malformations.-Maternal use of antiviral drugs, immunoglobulins, or vaccines and infant congenital malformations.-Maternal use of cytostatic/cytotoxic drugs or endocrine drugs used for malignancy and infant congenital malformations -- Maternal use of immunostimulating or immunosuppressive drugs and infant congenital malformations -- Maternal use of NSAID drugs and infant congenital malformations.-Maternal use of drugs other than NSAIDs for musculoskeletal diseases and infant congenital malformations -- Maternal use of opiates or opioid analgesics and infant congenital malformations -- Maternal use of mild analgesics and infant congenital malformations -- Maternal use of drugs for migraine and infant congenital malformations -- Maternal use of anticonvulsants and infant congenital malformations.-. Maternal use of antipsychotics and infant congenital malformations -- Maternal use of sedatives or hypnotics and infant congenital malformations -- Maternal use of antidepressants and infant congenital malformations -- Maternal use of other psychoactive drugs and infant congenital malformations -- Maternal use of antiprotozoans, antihelminthics or insecticides and infant congenital malformations -- Maternal use of nasal decongestants, other nasal preparations, or throat preparations and infant congenital malformations -- Maternal use of anti-asthmatics and infant congenital malformations -- Maternal use of cough and common cold medicines and infant congenital malformations -- Maternal use of drugs for nausea and vomiting in pregnancy and infant congenital malformations -- Maternal use of antihistamine drugs for allergy and infant congenital malformations -- Maternal use of local eye and ear drug therapy and infant congenital malformations -- Maternal use of some groups of drugs with common side effects and infant congenital malformations -- The practical consequences of observed associations between the use of drug and infant congenital malformation. |
| Record Nr. | UNINA-9910337532303321 |
|
Källén Bengt
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
New Approaches to Drug Discovery [[electronic resource] /] / edited by Ulrich Nielsch, Ulrike Fuhrmann, Stefan Jaroch
| New Approaches to Drug Discovery [[electronic resource] /] / edited by Ulrich Nielsch, Ulrike Fuhrmann, Stefan Jaroch |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (335 p.) |
| Disciplina | 615.19 |
| Collana | Handbook of Experimental Pharmacology |
| Soggetto topico |
Pharmacology
Pharmacy Medical biochemistry Metabolism Pharmacology/Toxicology Drug Safety and Pharmacovigilance Medical Biochemistry Metabolomics |
| ISBN | 3-319-28914-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Preface -- Part 1. Historical View -- Drug discovery in the past and today.Part 2. Target Discovery -- Emerging target families: intractable targets. In vivo target validation especially for biological targets. HR RNAi/High Content analysis -- Part 3. Lead generation and Optimization -- Sources for leads: natural products, libraries. Screening: assays, readout, technology. Impact of structural biology, fragment based screening/Virtual screening. Predictive in silico tools of compound properties. High throughput synthesis. New compound classes: Protein-Protein Interaction. Sources for biological leads/Screening of biologicals -- Part 4. Test systems for Efficacy and Safety -- In vitro / Cell based assays. Pharmacodynamic. Pharmacokinetic. Safety and toxicology. Impact of biomarkers/personalized medicine. Simulating in vivo drug effects. |
| Record Nr. | UNINA-9910253862103321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Novel Drug Delivery Technologies [[electronic resource] ] : Innovative Strategies for Drug Re-positioning / / edited by Ambikanandan Misra, Aliasgar Shahiwala
| Novel Drug Delivery Technologies [[electronic resource] ] : Innovative Strategies for Drug Re-positioning / / edited by Ambikanandan Misra, Aliasgar Shahiwala |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (XXIV, 431 p. 62 illus., 40 illus. in color.) |
| Disciplina | 615.6 |
| Soggetto topico |
Pharmacology
Pharmacy Medicinal chemistry Nanochemistry Pharmacology/Toxicology Drug Safety and Pharmacovigilance Medicinal Chemistry |
| ISBN | 981-13-3642-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Poorly water soluble drugs and formulation strategies to improve oral bioavailability -- Chapter 2. Buccal and intraoral drug delivery: Potential alternative to conventional therapy -- Chapter 3. Gastro-retentive drug delivery Systems: Current strategies and challenges -- Chapter 4. Peyer’s patch: Targeted drug delivery for therapeutics benefits -- Chapter 5. Colonic drug delivery systems as Multi-unit potential: Therapeutic strategies and opportunities -- Chapter 6. Controlled and prolonged drug delivery systems: Therapeutics needs and formulation strategies -- Chapter 7. Transdermal drug administration: Emerging techniques and improved patient compliance -- Chapter 8. Inhalation drug therapy: Emerging trends in Nasal and pulmonary drug delivery -- Chapter 9. Ophthalmic and otic drug administration: Novel approaches and challenges -- Chapter 10. Targeted drug delivery to brain: Challenges and formulation approaches -- Chapter 11. Opportunities and challenges in targeted carrier based drug delivery: Increased efficacy & reduced toxicity. |
| Record Nr. | UNINA-9910377838803321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Nutraceuticals in Veterinary Medicine [[electronic resource] /] / edited by Ramesh C. Gupta, Ajay Srivastava, Rajiv Lall
| Nutraceuticals in Veterinary Medicine [[electronic resource] /] / edited by Ramesh C. Gupta, Ajay Srivastava, Rajiv Lall |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (852 pages) |
| Disciplina | 613.2 |
| Soggetto topico |
Biochemistry
Veterinary medicine Nutrition Pharmacology Pharmacy Animal Biochemistry Veterinary Medicine/Veterinary Science Nutrition Pharmacology/Toxicology Drug Safety and Pharmacovigilance |
| ISBN | 3-030-04624-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I. Common Nutraceuticals -- Standardized Turmeric and Curcumin -- Fenugreek in Health and Disease -- Neem Extract -- Nutraceutical Potential of Ginger -- Berberine -- Sea Buckthorn and Apricot Based Nutraceuticals -- Nigella Sativa -- Babool (Acacia nilotica) -- Glucosinolates and Organosulfur Compounds -- Cannabis in Veterinary Medicine: Cannabinoid Therapies for Animals -- Essential Oils -- Omega Fatty Acids -- Polyphenols and Flavonoids -- Antioxidants in Prevention and Treatment of Diseases and Toxicity -- Resveratrol: Biological Activities and Potential Use in Health and Disease -- Egg Shell Membranes for Veterinary Uses -- Egg derived Ovotransferrins and Lactoferrins -- Colostrum Antibodies, Egg Antibodies and Monoclonal Antibodies Providing Passive Immunity for Animals -- Part II. Prebiotics, Probiotics, Synbiotics, and Antimicrobials -- Prebiotics and Probiotics in Feed and Animal Health -- Synbiotics in Animal Health and Production -- Enzymes in Feed and Animal Health -- Nutraceuticals Used as Antibacterial Alternatives in Animal Health and Disease -- Feed Additives in Animal Health -- Part III. Nutraceuticals in Organ- and System-Disorders -- Nutraceuticals in Arthritis -- Nutraceuticals for Antiaging -- Nutraceuticals for Cognitive Dysfunction -- Nutraceuticals for Calming and Stress -- Nutraceuticals in Cardiovascular Diseases -- Nutraceuticals in Hepatic and Pancreatic Diseases -- Nutraceuticals in Periodontal Health and Diseases in Dogs and Cats -- Nutraceuticals in Gastrointestinal Conditions -- Nutraceuticals in Reproductive Disorders -- Nutraceuticals in Genitourinary Maladies -- Nutraceuticals in Obesity and Metabolic Disorders -- Nutraceuticals for Diabetes in Dogs and Cats -- Nutraceuticals in Wound Healing: A Special Focus on Chromolaena Odorata as Guardian of Health with Broad Spectrum of Biological Activities -- Nutraceuticals in Dermatological Disorders -- Nutraceuticals in Mastitis -- Nutraceuticals in Immune Disorders -- Plant and Food Derived Immunomodulators as Nutraceuticals for Performance Enhancing Activities -- Nutraceuticals for the Prevention and Cure of Cancer -- Expanding Metabolic Targets in Cancer by Select Combinations of Vitamin C and EGCG with Different Natural Compounds -- Nutraceuticals for Control of Ticks, fleas and other Ectoparasites -- Part IV. Nutraceuticals in Specific Animal Species -- Nutraceuticals in Cattle Health and Diseases -- Nutraceuticals in Equine Medicine -- Nutraceuticals for Camelids -- Nutraceuticals in Poultry Health and Diseases -- Part V -- Safety and Toxicity Evaluation of Nutroceuticals and Functional Foods -- Safety and Toxicity Evaluation of Nutraceuticals in Animal Models -- Evaluation of Safety and Efficacy of Nutraceuticals using Drosophila as an in vivo Tool -- Biomarkers of Foods and Nutraceuticals: Applications in Efficacy, Safety and Therapy -- Toxicology and Drug Interactions of Nutraceuticals -- Part VI. Newer Trends in Nutraceutical Research and Product Development -- Proteomics in the Evaluation of Nutraceuticals and Functional Foods -- Nanoparticles and Molecular Delivery System for Nutraceuticals Bioavailability -- Nanosupplements and Animal Health -- Veterinary Nutraceuticals Stability Testing -- Part VII. Regulatory Aspects and Country-Specific Requirements for Nutraceuticals -- Basic Regulatory Guidelines for Veterinary Nutraceuticals -- Regulatory Aspects of Veterinary Nutraceuticals in the USA and Canada -- Regulatory Guidelines for Nutraceuticals in the European Union -- Regulatory Guidelines for Nutraceuticals and Food Supplements in India -- Uses and Regulatory Guidelines for Nutraceuticals in China -- Regulation of Nutraceuticals in Australia and New Zealand -- Regulatory Guidelines for Nutraceuticals and Dietary Supplements for Animals in Turkey -- Uses and Regulation of Nutraceuticals for Animals in the Philippines -- Regulatory Guidelines for Nutraceuticals in South Africa. |
| Record Nr. | UNINA-9910337948403321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Opioid therapy in infants, children, and adolescents / / edited by Ravi D. Shah, Santhanam Suresh
| Opioid therapy in infants, children, and adolescents / / edited by Ravi D. Shah, Santhanam Suresh |
| Edizione | [1st edition 2020.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
| Descrizione fisica | 1 online resource (xiii, 354 pages : 26 illustrations, 22 illustrations in color.) |
| Disciplina | 618.92 |
| Soggetto topico |
Pediatrics
Pharmacy Pain medicine Drug Safety and Pharmacovigilance Pain Medicine |
| ISBN | 3-030-36287-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Epidemiology and Public Health Implications of the Opioid Crisis -- The Impact of the Opioid Crisis on Neonates, Children, and Adolescents -- Legal Issues in Pediatric Opioid Therapy -- The Impetus for Recognizing, Preventing and Treating Pain in the Pediatric Population -- Evidence-Based Guidelines for Opioid Therapy in Pediatrics -- Neonatal and Pediatric Pharmacology -- Predicting Opioid Responsiveness in Pediatric Patients -- Emerging Trends in Pediatric Opioid Prescribing Practices -- Improving post-operative prescribing in pediatric patients by surgeons -- Assessing and managing opioid-related side effects in children and adolescents -- Identifying and Treating Opioid Misuse in Pediatric Patients -- Pediatric Pain Assessment and Indications for Opioids -- Pharmacologic Approaches to Pediatric Acute Pain States -- Regional Anesthesia for Acute Pain Management -- Opioid Therapy for Pediatric Cancer Pain -- Biopsychosocial Approaches to Pediatric Chronic Pain Management -- Non-Opioid Pharmacotherapy for Treatment of Pediatric Chronic Pain -- Interventional Approaches to Pediatric Chronic Pain Management -- Complementary and Integrative Medicine for Pediatric Chronic Pain. . |
| Record Nr. | UNINA-9910380726803321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Osteoarthritis [[electronic resource] ] : Pathogenesis, Diagnosis, Available Treatments, Drug Safety, Regenerative and Precision Medicine / / edited by Mohit Kapoor, Nizar N. Mahomed
| Osteoarthritis [[electronic resource] ] : Pathogenesis, Diagnosis, Available Treatments, Drug Safety, Regenerative and Precision Medicine / / edited by Mohit Kapoor, Nizar N. Mahomed |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 |
| Descrizione fisica | 1 online resource (283 p.) |
| Disciplina | 610 |
| Soggetto topico |
Rheumatology
Pharmacy Drug Safety and Pharmacovigilance |
| ISBN | 3-319-19560-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Pathogenesis of Osteoarthritis -- 2. Hip and Knee Osteoarthritis -- 3. Shoulder and Elbow Osteoarthritis -- 4. Lumbar Spine Osteoarthritis -- 5. Ankle Arthritis -- 6. Hand and Wrist Osteoarthritis -- 7. Imaging in Osteoarthritis -- 8. Osteoarthritis – Joint Conservation Strategies -- 9. Osteoarthritis Biomarkers -- 10. Drug/Agent Treatments for Osteoarthritis- Present and Future -- 11. Safety Profile of Current OA Therapies: Evidence from Clinical Trials -- 12. Regenerative Medicine Approaches for Treatment of Osteoarthritis -- 13. Precision Medicine for Osteoarthritis. |
| Record Nr. | UNINA-9910300164603321 |
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Pediatric Oncologic Pharmacy [[electronic resource] ] : A Complete Guide to Practice / / by Carolina Witchmichen Penteado Schmidt
| Pediatric Oncologic Pharmacy [[electronic resource] ] : A Complete Guide to Practice / / by Carolina Witchmichen Penteado Schmidt |
| Autore | Schmidt Carolina Witchmichen Penteado |
| Edizione | [1st ed. 2019.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 |
| Descrizione fisica | 1 online resource (179 pages) |
| Disciplina | 618.92994061 |
| Soggetto topico |
Pediatrics
Oncology Hematology Pharmacy Oncology Drug Safety and Pharmacovigilance |
| ISBN | 3-030-10988-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Introduction -- 2. Diseases in pediatric hemato/ oncology area and treatments -- 3. Diseases in rheumatology and their treatment with chemotherapy -- 4. Pharmacokinetics and pharmacodynamics of chemotherapy in children — The used drugs -- 5. Physical-chemical compatibility of drugs used in chemotherapy for children -- 6. Drug Interactions involving chemotherapy for children -- 7. Prescription analysis -- 8. Handling pediatric chemotherapy -- 9. Handling pediatric intrathecal drugs -- 10. Handling pediatric extemporaneous oral solutions with chemotherapy -- 11. Administration of a pediatric oncology pharmacy: from the purchase of the drugs to the dispensation -- 12. Chemotherapy for pediatric stem cell transplantation -- 13. Biosafety for pharmacists and technical team in pediatric chemotherapy area -- 14. Supportive therapy for pediatric patients receiving treatment with chemotherapy -- 15. Pediatric clinical pharmacy involving chemotherapy -- 16. Pediatric pharmaceutical care involving chemotherapy -- 17. Appendix -- 18. Reference. |
| Record Nr. | UNINA-9910337490203321 |
|
Schmidt Carolina Witchmichen Penteado
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Soggetto topico
-
Drug Safety and Pharmacovigilance
(49)
- Pharmacy (44)
- Pharmacology (16)
- Pharmacology/Toxicology (9)
- Pharmacovigilance (9)